Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis.
about
Suppression of ongoing experimental arthritis by a chinese herbal formula (huo-luo-xiao-ling dan) involves changes in antigen-induced immunological and biochemical mediators of inflammation.Immunomodulation of Autoimmune Arthritis by Herbal CAMThe investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover designElucidation of danzhixiaoyao wan and its constituent herbs on antioxidant activity and inhibition of nitric oxide production.Efficacy of kampo medicine in treating atopic dermatitis: an overview.Ameliorative effects of herbal combinations in hyperlipidemiaWhat has been overlooked on study of Chinese materia medica in the West?The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells.Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver.Effectiveness of keishibukuryogan on chronic-stage lichenification associated with atopic dermatitis.Asparagus root regulates cholesterol metabolism and improves antioxidant status in hypercholesteremic rats.Anti-inflammatory activity of the methanol extract of moutan cortex in LPS-activated Raw264.7 cells.Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences.Oral Administration of the Japanese Traditional Medicine Keishibukuryogan-ka-yokuinin Decreases Reactive Oxygen Metabolites in Rat Plasma: Identification of Chemical Constituents Contributing to Antioxidant Activity.Antioxidant and ACE enhancing potential of Pankajakasthuri in fluoride toxicity: an in vitro study on mammalian lungs.
P2860
Q34219054-B003810F-CE94-4EC8-B306-ADF637EBEE53Q34460609-36BED7C5-0A6E-4C4B-99E0-CF5BCB0A7047Q34596187-266FAF34-CF58-4CBF-B5B0-9707F9032DC8Q35999697-606329F1-A0E1-479D-8779-0B7CC5D00110Q36330764-B26B10EF-1BC3-4CA1-BB13-BB0EA66BDDCEQ38196809-DE86C0C3-ABA0-40D0-8351-8C9750C2CCFDQ38445613-8433DEDE-2CD5-4C0C-ADED-FB7AB115E569Q38544110-8AAD195E-CF80-43B5-A833-0801EA0A0D33Q39604917-86B0FEC8-BBE7-436B-8D38-5933C3250AFFQ40120793-64543A89-13FF-44A0-AD71-E74AD80F0FF6Q41731576-B4D1233F-4EF0-4136-9676-ED6A0366446FQ41839306-301ECDCF-47C8-4D44-B99B-20DFDCDA231DQ42370660-D4228E7E-88C5-4D3B-B452-2A18FD09EA79Q42427086-401FB863-12D4-47F3-AEE2-9C90507C37CDQ46416757-53BCB8D2-1305-4517-B651-A201341992E2Q47309769-F4C58B2B-F70C-4F40-8D49-59944419E541
P2860
Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@ast
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@en
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@nl
type
label
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@ast
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@en
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@nl
prefLabel
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@ast
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@en
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Keishibukuryogan (gui-zhi-fu-l ...... nts with rheumatoid arthritis.
@en
P2093
Hiroaki Hikiami
Hirozo Goto
Kazuya Nozaki
Naotoshi Shibahara
Takako Nakagawa
Yutaka Shimada
P2860
P304
P356
10.1093/ECAM/NEL025
P577
2006-09-01T00:00:00Z